SPOTLIGHT -
These medical apps provided technology for caregivers to track symptoms, make appointments with doctors, monitor medications, and more.
Neuro News Roundup: TBI Awareness Month
Special Episode: Lecanemab Approved for Alzheimer Disease
Raising Awareness on Traumatic Brain Injury and Significance of Abbott’s Approved Alinity i Lab-Based Blood Test
Episode 79: A New Monoclonal for Alzheimer Disease
Blarcamesine Deemed Safe, Effective in Phase 2 Extension Study of Parkinson Disease Dementia
New Analysis of Phase 3 Clarity AD Study Highlights Health and Economic Benefits From Lecanemab